Silexion Therapeutics Corp. (SLXN)
NASDAQ · Healthcare
Silexion Therapeutics Corp. Net Income 2023–2025
Silexion Therapeutics Corp. annual/quarterly net income history and growth rate from 2023 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Silexion Therapeutics Corp. net income for the quarter ending March 31, 2026 was -2.7 M, a 57.52% increase year-over-year.
- Silexion Therapeutics Corp. net income for the twelve months ending March 31, 2026 was -10.2 M.
- Silexion Therapeutics Corp. annual net income for 2025 was -11.9 M, a 27.89% decrease from 2024.
- Silexion Therapeutics Corp. annual net income for 2024 was -16.5 M, a 223.39% increase from 2023.
- Silexion Therapeutics Corp. annual net income for 2023 was -5.1 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Silexion Therapeutics Corp. Net Income — FAQ
Silexion Therapeutics Corp. (SLXN) net income over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is Silexion Therapeutics Corp.'s net income?
Silexion Therapeutics Corp. (SLXN) reported net income of -$12M for fiscal 2025.
Where can I see SLXN's net income history?
The chart and table above show Silexion Therapeutics Corp.'s net income by year and by quarter, including the growth rate.